Germany
· Delayed Price · Currency is EUR Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of EUR 271.14 billion. The enterprise value is 295.05 billion.
| Market Cap | 271.14B |
| Enterprise Value | 295.05B |
Important Dates
The next estimated earnings date is Thursday, October 31, 2024.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | Sep 16, 2024 |
Share Statistics
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.97% |
| Shares Change (QoQ) | -0.88% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.53B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.65, with an EV/FCF ratio of 24.05.
| EV / Earnings | 23.01 |
| EV / Sales | 5.24 |
| EV / EBITDA | 13.65 |
| EV / EBIT | 16.55 |
| EV / FCF | 24.05 |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 86.57.
| Current Ratio | 1.47 |
| Quick Ratio | 0.93 |
| Debt / Equity | 86.57 |
| Debt / EBITDA | 1.58 |
| Debt / FCF | 2.87 |
| Interest Coverage | 15.94 |
Financial Efficiency
Return on equity (ROE) is 33.38% and return on invested capital (ROIC) is 15.73%.
| Return on Equity (ROE) | 33.38% |
| Return on Assets (ROA) | 11.38% |
| Return on Capital (ROIC) | 15.73% |
| Revenue Per Employee | 821,304 |
| Profits Per Employee | 180,561 |
| Employee Count | 72,000 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.44 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.61% in the last 52 weeks. The beta is 0.40, so Merck & Co.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +8.61% |
| 50-Day Moving Average | 109.64 |
| 200-Day Moving Average | 112.42 |
| Relative Strength Index (RSI) | 53.26 |
| Average Volume (20 Days) | 1,323 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.61 |
Income Statement
In the last 12 months, Merck & Co. had revenue of EUR 58.31 billion and earned 12.82 billion in profits. Earnings per share was 5.03.
| Revenue | 58.31B |
| Gross Profit | 44.19B |
| Operating Income | 18.45B |
| Pretax Income | 14.23B |
| Net Income | 12.82B |
| EBITDA | 22.06B |
| EBIT | 18.45B |
| Earnings Per Share (EPS) | 5.03 |
Balance Sheet
The company has 10.60 billion in cash and 35.27 billion in debt, giving a net cash position of -24.67 billion.
| Cash & Cash Equivalents | 10.60B |
| Total Debt | 35.27B |
| Net Cash | -24.67B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 40.74B |
| Book Value Per Share | 16.04 |
| Working Capital | 11.33B |
Cash Flow
In the last 12 months, operating cash flow was 15.58 billion and capital expenditures -3.31 billion, giving a free cash flow of 12.27 billion.
| Operating Cash Flow | 15.58B |
| Capital Expenditures | -3.31B |
| Free Cash Flow | 12.27B |
| FCF Per Share | n/a |
Margins
Gross margin is 75.79%, with operating and profit margins of 31.64% and 21.98%.
| Gross Margin | 75.79% |
| Operating Margin | 31.64% |
| Pretax Margin | 24.41% |
| Profit Margin | 21.98% |
| EBITDA Margin | 37.82% |
| EBIT Margin | 31.64% |
| FCF Margin | 21.04% |
Dividends & Yields
Merck & Co. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | 3.10% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 55.64% |
| Buyback Yield | 1.97% |
| Shareholder Yield | 1.97% |
| Earnings Yield | 4.69% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |